Navigation Links
AMERIGROUP Successful Bidder in DC RFP
Date:4/2/2008

Company Evaluating Business in Light of Unresolved Audit Issues

VIRGINIA BEACH, Va., April 2, 2008 /PRNewswire-FirstCall/ -- On March 10, 2008, AMERIGROUP DC was notified that it was one of four successful bidders in the reprocurement of the District of Columbia's Medicaid managed care business. The contracts for this award were approved by City Council on March 22nd and AMERIGROUP DC had been engaged in final preparations for a start date of May 1, 2008.

Yesterday, the Company notified the District that it was suspending its participation in readiness review activities related to the new contract award, due to questions the District has raised regarding the calculation of rates.

For the past few weeks, the Company has been engaged in a dialogue with the District's Office of the Attorney General in its review of these questions, which were raised in connection with an audit completed in May 2007. On March 28, the District filed a complaint in D.C. Superior Court alleging that AMERIGROUP DC submitted a report to its regulators in which it misclassified or improperly included certain administrative costs as healthcare costs.

"We believe that the allegations advanced in the complaint are without merit and based upon a fundamental misunderstanding of well-established rating and regulatory requirements and, in any event, are not material to rate calculations," said James W. Truess, Executive Vice President and Chief Financial Officer. "In the normal course of business, these kinds of issues are resolved through direct communications between a vendor and the regulatory agencies with oversight responsibility."

"We are concerned that the complaint also calls into question the appropriateness of rates in the new contract," Truess continued. "While we remain hopeful that we can resolve these questions quickly, we cannot proceed with the FY 2009 contract while they remain outstanding."

AMERIGROUP Community Care of the District of Columbia currently serves about 38,000 financially vulnerable D.C. residents who are enrolled in Medicaid and has operated in the District for nine years.

About AMERIGROUP Corporation

AMERIGROUP Corporation (NYSE: AGP), headquartered in Virginia Beach, Virginia, improves healthcare access and quality for the financially vulnerable, seniors and people with disabilities by developing innovative managed health services for the public sector. Through its subsidiaries, AMERIGROUP Corporation serves more than 1.7 million people in the District of Columbia, Florida, Georgia, Maryland, New Jersey, New York, Ohio, South Carolina, Tennessee, Texas and Virginia. For more information, visit http://www.amerigroupcorp.com.

CONTACTS:

Investors: Julie Loftus Trudell

AMERIGROUP Corporation

SVP, Investor Relations

(757) 321-3597

News Media: Kent Jenkins, Jr.

AMERIGROUP Corporation

SVP, External Communications

(757) 769-7859


'/>"/>
SOURCE AMERIGROUP Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Texas Senator Kirk Watson Honored as Champion for Children by the AMERIGROUP Foundation
2. AMERIGROUP Updates 2008 Guidance to Reflect Yesterdays Federal Reserve Action
3. AMERIGROUP Corporation to Present at the Lehman Brothers Global Healthcare Conference on March 20
4. Texas Senator Robert Duncan Honored as Champion for Children by The AMERIGROUP Foundation
5. AMERIGROUP Reports Q4 Net Income of $31.1 Million or $0.57 Per Diluted Share; Full-Year Net Income of $116.5 Million or $2.16 Per Diluted Share
6. Texas Senator Tommy Williams Honored as Champion for Children by the AMERIGROUP Foundation
7. AMERIGROUP Foundation Announces Winners of Word About Health Contest
8. AMERIGROUP Names Linda Whitley-Taylor as Executive Vice President, Associate Services
9. AMERIGROUP Community Care of Georgia Wins New Health Plan Accreditation from NCQA
10. AMERIGROUP Foundation Awards $100,000 to Grady Health System Foundation in Atlanta
11. AMERIGROUP Community Care Provides Doctors Office Makeover in Houston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... ... Robert E. Burke, MD, PhD, had a successful career as a pediatrician ... could have led him down a much different path. , In his book, “Beyond ... Pediatrics,” Dr. Burke shares a personal account of the tribulations he encountered on his ...
(Date:2/27/2017)... ... February 27, 2017 , ... The threat of nuclear warfare has long ... company involved in the underground testing of nuclear weapons. Years later, when her co-workers ... of the Cold War Nuclear Testing,” Clayton exposes the critical decisions made by agencies ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... an overview on laser diffraction analysis as a tool to characterize particle size ... and potential to obtain improved results and novel scientific findings. It describes methods ...
(Date:2/27/2017)... ... February 27, 2017 , ... Texas based retail electric company ... Power's RCE (Residential Customer Equivalent) count exceeds 150,000. , Discount Power ... customers and 2,250 RCEs at the time of acquisition. In the three years ...
(Date:2/27/2017)... San Francisco, CA (PRWEB) , ... February 27, ... ... transplant clinic serving San Francisco and environs, is proud to announce an upgrade ... research information on the upgraded Yelp page on topics as diverse as Platelet ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Feb. 27, 2017  A landmark study ... , MBBS, PhD, FRACS, of  Sydney Heart and ... Sydney will be published in the February 28, ... American College of Cardiology . According to the study, which ... bypass surgery technique (anOPCABG) reduced postoperative stroke ...
(Date:2/27/2017)...  International Biophysics Corporation, a global medical device manufacturer based ... 34% revenue growth in 2016 when compared to the previous ... growth was fueled by its AffloVest® sales in ... of its global sales of surgical product lines. ... enter our 25 th year in delivering high-quality, innovative ...
(Date:2/27/2017)... Md. , Feb. 27, 2017  RegeneRx ... a clinical-stage drug development company focused on tissue ... licensee for RGN-137, GtreeBNT Co., Ltd., received a ... Phase 3 clinical trial design for RGN-137 to ... wound healing gel that incorporates Thymosin beta 4 ...
Breaking Medicine Technology: